Retrospective study to assess axillary management and oncological outcome after neoadjuvant chemotherapy for patients with breast cancer

Evaluation of targeted axillary dissection in node positive locally advanced breast cancer patients with complete pathological response to neoadjuvant chemotherapy

Evaluation of Sentinel Lymph Node Biopsy after Neoadjuvant Therapy for Breast Cancer Patients with Positive Axillary Nodes: A Multicenter Study

Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer

SENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY IN CLINICALLY NODE POSITIVE AXILLA OF BREAST CANCER

Validity of sentinel lymph nodes biopsy after neoadjuvant chemotherapy in case of complete pathological response of axillary lymph nodes

EVALUATION OF THE AXILLARY NODAL STATUS POST NEO-ADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED FEMALE BREAST CANCER PATIENTS

RETROSPECTIVE STUDY TO ASSESS AXILLARY MANAGEMENT AND ONCOLOGICAL OUTCOME AFTER NEOADJUVANT CHEMOTHERAPY FOR BREAST CANCER PATIENTS

Predictive Role of Molecular Subtypes in Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

How much is the axillary nodal status in breast cancer affected by neoadjuvant chemotherapy? An Alexandria medical research institute hospital experience